Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.

The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling. Proc Natl Acad Sci U S A. 2006 Dec 05; 103(49):18715-20.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.